{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,22]],"date-time":"2026-11-22T04:11:07Z","timestamp":1795320667120,"version":"4.10.3"},"reference-count":295,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2023,9,5]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts from various specialties involved in the management of CCA, as well as patient\/public representatives from AMMF (the Cholangiocarcinoma Charity) and PSC Support. Quality of evidence is presented using the Appraisal of Guidelines for Research and Evaluation (AGREE II) format. The recommendations arising are to be used as guidance rather than as a strict protocol-based reference, as the management of patients with CCA is often complex and always requires individual patient-centred considerations.<\/jats:p>","DOI":"10.1136\/gutjnl-2023-330029","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:20:44Z","timestamp":1695907244000},"page":"16-46","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":106,"title":["British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma"],"prefix":"10.1136","volume":"73","clinical-trial-number":[{"clinical-trial-number":"nct02232932","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"isrctn10639376","registry":"10.18810\/isrctn"}],"author":[{"given":"Simon M","family":"Rushbrook","sequence":"first","affiliation":[{"name":"Department of Hepatology, Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-2786","authenticated-orcid":false,"given":"Timothy James","family":"Kendall","sequence":"additional","affiliation":[{"name":"Division of Pathology, University of Edinburgh, Edinburgh, UK"},{"name":"University of Edinburgh MRC Centre for Inflammation Research, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[{"name":"Department of Pathology, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raneem","family":"Albazaz","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Manoharan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Christie Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P","family":"Pereira","sequence":"additional","affiliation":[{"name":"GI Divison, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sturgess","sequence":"additional","affiliation":[{"name":"Digestive Diseases Unit, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R","family":"Davidson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Royal Free Campus, UCL Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Z","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Aintree, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Manas","sequence":"additional","affiliation":[{"name":"Department of Surgery, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Heaton","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Raj","family":"Prasad","sequence":"additional","affiliation":[{"name":"John Goligher Colorectal Unit, St. James University Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bridgewater","sequence":"additional","affiliation":[{"name":"Department of Oncology, UCL Cancer Institute, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan W","family":"Valle","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The Christie NHS Foundation Trust\/University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Goody","sequence":"additional","affiliation":[{"name":"Department of Oncology, St James's University Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Department of Medical Physics and Biomedical Engineering, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Prentice","sequence":"additional","affiliation":[{"name":"King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Morement","sequence":"additional","affiliation":[{"name":"AMMF, Essex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Walmsley","sequence":"additional","affiliation":[{"name":"Chair of Trustees PSC Support, Didcot, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-0911","authenticated-orcid":false,"given":"Shahid A","family":"Khan","sequence":"additional","affiliation":[{"name":"Hepatology and Gastroenterology Section, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"},{"name":"Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"2025112102451055000_73.1.16.1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301748"},{"key":"2025112102451055000_73.1.16.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2025112102451055000_73.1.16.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"2025112102451055000_73.1.16.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67530-7"},{"key":"2025112102451055000_73.1.16.5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025112102451055000_73.1.16.6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/liv.14098","article-title":"The tumour microenvironment and immune milieu of cholangiocarcinoma","volume":"39 Suppl 1","author":"Fabris","year":"2019","journal-title":"Liver Int"},{"key":"2025112102451055000_73.1.16.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0310-z"},{"key":"2025112102451055000_73.1.16.8","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199610000-00005"},{"key":"2025112102451055000_73.1.16.9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39 Suppl 1","author":"Khan","year":"2019","journal-title":"Liver Int"},{"key":"2025112102451055000_73.1.16.10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.6.816"},{"key":"2025112102451055000_73.1.16.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00297-0"},{"key":"2025112102451055000_73.1.16.12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejso.2020.03.222","article-title":"Epidemiology of HPB malignancy in the elderly","volume":"47","author":"Pericleous","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2025112102451055000_73.1.16.13","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"key":"2025112102451055000_73.1.16.14","doi-asserted-by":"crossref","unstructured":"Tataru D , Khan SA , Hill R . Cholangiocarcinoma across England: a national study of temporal changes in incidence, survival and routes to diagnosis by region and socioeconomic deprivation (in press). J Hep Rep 2023.","DOI":"10.1016\/j.jhepr.2023.100983"},{"key":"2025112102451055000_73.1.16.15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejso.2020.09.039","article-title":"Cholangiocarcinoma miscoding in hepatobiliary centres","volume":"47","author":"Selvadurai","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2025112102451055000_73.1.16.16","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.157"},{"key":"2025112102451055000_73.1.16.17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jhep.2020.02.029","article-title":"\u201c[reply to: 'letter regarding [risk factors for Intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis]'\u201d","volume":"72","author":"Khan","year":"2020","journal-title":"J Hepatol"},{"key":"2025112102451055000_73.1.16.18","unstructured":"WHO . WHO Classification of Tumours, 5th Edition, Volume 1. Digestive System Tumours, Available: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Digestive-System-Tumours-2019 [Accessed 14 Oct 2021]."},{"key":"2025112102451055000_73.1.16.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-9970-0"},{"key":"2025112102451055000_73.1.16.20","unstructured":"Burt A , Alves V , Coulston A , et al . Intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma histopathology reporting guide. 2nd ed. Sydney, Australia: International Collaboration on Cancer Reporting, 2020. Available: https:\/\/www.iccr-cancer.org\/datasets\/published-datasets\/digestive-tract\/liver\/"},{"key":"2025112102451055000_73.1.16.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04048.x"},{"key":"2025112102451055000_73.1.16.22","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0000000000000957","article-title":"C-reactive protein (CRP) is a promising diagnostic immunohistochemical marker for intrahepatic cholangiocarcinoma and is associated with better prognosis","volume":"41","author":"Yeh","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"2025112102451055000_73.1.16.23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2020.12.005","article-title":"An immunostaining panel of C-reactive protein, N-Cadherin, and S100 calcium binding protein P is useful for Intrahepatic cholangiocarcinoma subtyping","volume":"109","author":"Akita","year":"2021","journal-title":"Hum Pathol"},{"key":"2025112102451055000_73.1.16.24","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.22"},{"key":"2025112102451055000_73.1.16.25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2025112102451055000_73.1.16.26","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3375"},{"key":"2025112102451055000_73.1.16.27","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"key":"2025112102451055000_73.1.16.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30109-1"},{"key":"2025112102451055000_73.1.16.29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41416-018-0199-2","article-title":"Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma","volume":"120","author":"Goeppert","year":"2019","journal-title":"Br J Cancer"},{"key":"2025112102451055000_73.1.16.30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ajcp\/aqz199","article-title":"Mismatch repair protein deficiency\/microsatellite instability is rare in cholangiocarcinomas and associated with distinctive morphologies","volume":"153","author":"Ju","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"2025112102451055000_73.1.16.31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jhbp.988","article-title":"Prediction of mismatch repair deficient biliary tract cancer: role of morphological features and host immune response detected by routine hematoxylin-eosin staining","volume":"28","author":"Suda","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2025112102451055000_73.1.16.32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1200\/JCO.2020.38.4_suppl.574","article-title":"NTRK gene fusions in biliary tract cancers","volume":"38","author":"Demols","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025112102451055000_73.1.16.33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29789"},{"key":"2025112102451055000_73.1.16.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02468.x"},{"key":"2025112102451055000_73.1.16.35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/his.13884","article-title":"Keratin 19-expressing hepatocellular carcinoma and small-duct type Intrahepatic cholangiocarcinoma show a similar postoperative clinical course but have distinct genetic features","volume":"75","author":"Akita","year":"2019","journal-title":"Histopathology"},{"key":"2025112102451055000_73.1.16.36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.5243","article-title":"Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma","volume":"248","author":"Joseph","year":"2019","journal-title":"J Pathol"},{"key":"2025112102451055000_73.1.16.37","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","article-title":"Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity","volume":"66","author":"Moeini","year":"2017","journal-title":"J Hepatol"},{"key":"2025112102451055000_73.1.16.38","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800788"},{"key":"2025112102451055000_73.1.16.39","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9123991","article-title":"Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and molecular and genetic alterations","volume":"9","author":"Nakanuma","year":"2020","journal-title":"J Clin Med"},{"key":"2025112102451055000_73.1.16.40","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/his.13037","article-title":"Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas","volume":"69","author":"Fujikura","year":"2016","journal-title":"Histopathology"},{"key":"2025112102451055000_73.1.16.41","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1007\/s00330-018-5841-0","article-title":"CT imaging comparison between Intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas","volume":"29","author":"Komori","year":"2019","journal-title":"Eur Radiol"},{"key":"2025112102451055000_73.1.16.42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/PAS.0000000000001237","article-title":"Intracholecystic papillary neoplasms are distinct from papillary gallbladder cancers","volume":"43","author":"Akita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"2025112102451055000_73.1.16.43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/PAS.0000000000000963","article-title":"Hepatobiliary mucinous cystic neoplasms with ovarian type stroma (so-called \u201chepatobiliary cystadenoma\/cystadenocarcinoma","volume":"42","author":"Quigley","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"2025112102451055000_73.1.16.44","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.71"},{"key":"2025112102451055000_73.1.16.45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MPA.0b013e3181f3aa96","article-title":"Factors affecting the yield of brush cytology for the diagnosis of pancreatic and biliary cancers","volume":"40","author":"Parsi","year":"2011","journal-title":"Pancreas"},{"key":"2025112102451055000_73.1.16.46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2169\/internalmedicine.1551-18","article-title":"Investigation of factors affecting the sensitivity of bile duct brush cytology","volume":"58","author":"Kobayashi","year":"2019","journal-title":"Intern Med"},{"key":"2025112102451055000_73.1.16.47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5946\/ce.2019.053","article-title":"Endoscopic ultrasound-guided fine needle aspiration and endoscopic retrograde cholangiopancreatography-based tissue sampling in suspected malignant biliary strictures: a meta-analysis of same-session procedures","volume":"53","author":"de Moura","year":"2020","journal-title":"Clin Endosc"},{"key":"2025112102451055000_73.1.16.48","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s10620-020-06335-x","article-title":"Combination of ERCP-based modalities increases diagnostic yield for biliary strictures","volume":"66","author":"Han","year":"2021","journal-title":"Dig Dis Sci"},{"key":"2025112102451055000_73.1.16.49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10620-018-4906-x","article-title":"Role of fluorescent in situ hybridization, cholangioscopic biopsies, and EUS-FNA in the evaluation of biliary strictures","volume":"63","author":"Brooks","year":"2018","journal-title":"Dig Dis Sci"},{"key":"2025112102451055000_73.1.16.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2013.11.001"},{"key":"2025112102451055000_73.1.16.51","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317817"},{"key":"2025112102451055000_73.1.16.52","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/gou072"},{"key":"2025112102451055000_73.1.16.53","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-21-0189"},{"key":"2025112102451055000_73.1.16.54","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/88405305"},{"key":"2025112102451055000_73.1.16.55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.21037\/hbsn.2016.12.10","article-title":"Multimodality imaging of intrahepatic cholangiocarcinoma","volume":"6","author":"F\u00e1brega-Foster","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2025112102451055000_73.1.16.56","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00261-016-0943-0","article-title":"MDCT assessment of resectability in hilar cholangiocarcinoma","volume":"42","author":"Ni","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"2025112102451055000_73.1.16.57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1148\/radiol.2018171187","article-title":"Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges","volume":"288","author":"Joo","year":"2018","journal-title":"Radiology"},{"key":"2025112102451055000_73.1.16.58","first-page":"59","article-title":"Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging","volume":"38","author":"Kuszyk","year":"1997","journal-title":"Crit Rev Diagn Imaging"},{"key":"2025112102451055000_73.1.16.59","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22441"},{"key":"2025112102451055000_73.1.16.60","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.1289"},{"key":"2025112102451055000_73.1.16.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2006.10.024"},{"key":"2025112102451055000_73.1.16.62","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s00261-013-0027-3","article-title":"Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection","volume":"38","author":"Joo","year":"2013","journal-title":"Abdom Imaging"},{"key":"2025112102451055000_73.1.16.63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2019.01.038","article-title":"18F-Fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: systematic review and meta-analysis","volume":"71","author":"Lamarca","year":"2019","journal-title":"J Hepatol"},{"key":"2025112102451055000_73.1.16.64","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/RCT.0b013e318184f3f7","article-title":"Evaluation of the gross type and longitudinal extent of extrahepatic cholangiocarcinomas on contrast-enhanced multidetector row computed tomography","volume":"33","author":"Seo","year":"2009","journal-title":"J Comput Assist Tomogr"},{"key":"2025112102451055000_73.1.16.65","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.21037\/qims-20-1303","article-title":"Multidetector computed tomography assessment of vascular involvement in perihilar cholangiocarcinoma","volume":"11","author":"Franken","year":"2021","journal-title":"Quant Imaging Med Surg"},{"key":"2025112102451055000_73.1.16.66","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2383050419"},{"key":"2025112102451055000_73.1.16.67","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020932","article-title":"Comparison of magnetic resonance imaging and 18-fluorodeoxyglucose positron emission tomography\/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2025112102451055000_73.1.16.68","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/hep4.1774","article-title":"Clinical staging of mass\u2010forming intrahepatic cholangiocarcinoma: computed tomography versus magnetic resonance imaging","volume":"5","author":"Kim","year":"2021","journal-title":"Hepatol Commun"},{"key":"2025112102451055000_73.1.16.69","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3348\/kjr.2013.14.6.894","article-title":"MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid","volume":"14","author":"Lee","year":"2013","journal-title":"Korean J Radiol"},{"key":"2025112102451055000_73.1.16.70","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-010-1842-3"},{"key":"2025112102451055000_73.1.16.71","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00330-015-3846-5","article-title":"Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI","volume":"26","author":"Koh","year":"2016","journal-title":"Eur Radiol"},{"key":"2025112102451055000_73.1.16.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2011.12.040"},{"key":"2025112102451055000_73.1.16.73","doi-asserted-by":"publisher","DOI":"10.1177\/0284185113502017"},{"key":"2025112102451055000_73.1.16.74","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jmri.24403","article-title":"Optimal B value in diffusion-weighted imaging for differentiation of abdominal lesions","volume":"40","author":"Koc","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"2025112102451055000_73.1.16.75","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/RLI.0b013e3181d2eeb1","article-title":"Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer","volume":"45","author":"Ryoo","year":"2010","journal-title":"Invest Radiol"},{"key":"2025112102451055000_73.1.16.76","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jmri.23957","article-title":"Gadoxetic acid-enhanced MRI with MR cholangiography for the preoperative evaluation of bile duct cancer","volume":"38","author":"Sun","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"2025112102451055000_73.1.16.77","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2310"},{"key":"2025112102451055000_73.1.16.78","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0043-122496","article-title":"Biopsy of liver target lesions under contrast-enhanced ultrasound guidance \u2013 a multi-center study","volume":"39","author":"Francica","year":"2018","journal-title":"Ultraschall Med"},{"key":"2025112102451055000_73.1.16.79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2468-1253(18)30267-X","article-title":"How should we drain malignant obstruction at the liver hilum?","volume":"3","author":"Bridgewater","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112102451055000_73.1.16.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2016.01.060"},{"key":"2025112102451055000_73.1.16.81","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.hpb.2016.06.009","article-title":"Fast and accurate liver volumetry prior to hepatectomy","volume":"18","author":"Lodewick","year":"2016","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.82","doi-asserted-by":"crossref","first-page":"109779","DOI":"10.1016\/j.ejrad.2021.109779","article-title":"Quantitative assessment of liver function with hepatocyte fraction: comparison with T1 relaxation-based indices","volume":"141","author":"Bi","year":"2021","journal-title":"Eur J Radiol"},{"key":"2025112102451055000_73.1.16.83","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrgastro.2018.10","article-title":"Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD","volume":"15","author":"Tapper","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025112102451055000_73.1.16.84","unstructured":"American College of Radiology . CT\/MRI LI-RADS\u00ae V2018 core. 2018. Available: https:\/\/www.acr.org\/-\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-2018-Core.pdf?la=en [Accessed 27 2022]."},{"key":"2025112102451055000_73.1.16.85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2015.11.017","article-title":"Cholangiocarcinoma: current opinion on clinical practice diagnostic and therapeutic Algorithms","volume":"48","author":"Brandi","year":"2016","journal-title":"Digestive and Liver Disease"},{"key":"2025112102451055000_73.1.16.86","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jgh.14528","article-title":"Same\u2010session endoscopic ultrasound\u2010guided fine needle aspiration and endoscopic retrograde cholangiopancreatography\u2010based tissue sampling in suspected malignant biliary obstruction: a multicenter experience","volume":"34","author":"Jo","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"2025112102451055000_73.1.16.87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/a-1375-9775","article-title":"Endoscopic ultrasound (EUS)-guided fine needle biopsy alone vs. EUS-guided fine needle aspiration with rapid onsite evaluation in pancreatic lesions: a multicenter randomized trial","volume":"54","author":"Chen","year":"2022","journal-title":"Endoscopy"},{"key":"2025112102451055000_73.1.16.88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.giec.2018.12.003","article-title":"Practical management of indeterminate biliary strictures","volume":"29","author":"Novikov","year":"2019","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"2025112102451055000_73.1.16.89","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-995566"},{"key":"2025112102451055000_73.1.16.90","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/1742-6413.133343","article-title":"Standardized terminology and nomenclature for pancreatobiliary cytology: the Papanicolaou Society of Cytopathology guidelines","volume":"11","author":"Pitman","year":"2014","journal-title":"CytoJournal"},{"key":"2025112102451055000_73.1.16.91","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1007\/s10620-021-07138-4","article-title":"Brush cytology, forceps biopsy, or endoscopic ultrasound-guided sampling for diagnosis of bile duct cancer: a meta-analysis","volume":"67","author":"Yoon","year":"2022","journal-title":"Dig Dis Sci"},{"key":"2025112102451055000_73.1.16.92","doi-asserted-by":"crossref","first-page":"733","DOI":"10.14309\/ajg.0000000000001666","article-title":"More endoscopy-based brushing passes improve the detection of malignant biliary strictures: a multicenter randomized controlled trial","volume":"117","author":"Wang","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2025112102451055000_73.1.16.93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000488636","article-title":"Urovysion multi-target fluorescence in situ hybridization assay for the detection of malignant bile duct brushing specimens: a comparison with routine cytology","volume":"62","author":"Zhai","year":"2018","journal-title":"Acta Cytol"},{"key":"2025112102451055000_73.1.16.94","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/1751-2980.12311","article-title":"Predictive factors for positive diagnosis of malignant biliary strictures by transpapillary brush cytology and forceps biopsy","volume":"17","author":"Naitoh","year":"2016","journal-title":"J Dig Dis"},{"key":"2025112102451055000_73.1.16.95","first-page":"253","article-title":"Digital cholangioscopy (Spyglass) in the diagnosis of cholangiocarcinoma","volume":"30","author":"Dimas","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"2025112102451055000_73.1.16.96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gie.2014.12.021","article-title":"Is single-operator peroral cholangioscopy a useful tool for the diagnosis of indeterminate biliary lesion? A systematic review and meta-analysis","volume":"82","author":"Sun","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"2025112102451055000_73.1.16.97","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.gie.2015.04.030","article-title":"Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review","volume":"82","author":"Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"2025112102451055000_73.1.16.98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1477-2574.2011.00298.x"},{"key":"2025112102451055000_73.1.16.99","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8040417","article-title":"Endoscopic ultrasonography-guided fine needle aspiration for extrahepatic cholangiocarcinoma: a safe tissue sampling modality","volume":"8","author":"Onoyama","year":"2019","journal-title":"J Clin Med"},{"key":"2025112102451055000_73.1.16.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2011.05.009"},{"key":"2025112102451055000_73.1.16.101","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2533-5"},{"key":"2025112102451055000_73.1.16.102","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325178"},{"key":"2025112102451055000_73.1.16.103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0903230"},{"key":"2025112102451055000_73.1.16.104","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.dld.2021.07.010","article-title":"Difficult biliary cannulation in patients with distal malignant biliary obstruction: an underestimated problem?","volume":"54","author":"Fugazza","year":"2022","journal-title":"Dig Liver Dis"},{"key":"2025112102451055000_73.1.16.105","unstructured":"NICE (National Institute for Health and Care Excellence) . Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cancer Interventional procedures guidance [IPG614], Available: https:\/\/www.nice.org.uk\/guidance\/IPG614\/chapter\/1-Recommendations [Accessed 11 Feb 2023]."},{"key":"2025112102451055000_73.1.16.106","doi-asserted-by":"publisher","DOI":"10.1055\/a-0659-9864"},{"key":"2025112102451055000_73.1.16.107","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.3748\/wjg.v21.i47.13374","article-title":"Endoscopic stenting for inoperable malignant biliary obstruction: a systematic review and meta-analysis","volume":"21","author":"Pu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2025112102451055000_73.1.16.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2015.03.1980"},{"key":"2025112102451055000_73.1.16.109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149066","article-title":"Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: a meta-analysis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS ONE"},{"key":"2025112102451055000_73.1.16.110","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.gie.2021.12.032","article-title":"EUS-guided choledochoduodenostomy for malignant distal biliary obstruction after failed ERCP: a retrospective nationwide analysis","volume":"95","author":"Fugazza","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"2025112102451055000_73.1.16.111","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.51"},{"key":"2025112102451055000_73.1.16.112","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/13651820801992591","article-title":"Staging of cholangiocarcinoma: the role of endoscopy","volume":"10","author":"Rauws","year":"2008","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.113","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cgh.2020.05.035","article-title":"An unsuccessful randomized trial of percutaneous vs endoscopic drainage of suspected malignant hilar obstruction","volume":"19","author":"Elmunzer","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112102451055000_73.1.16.114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14218\/JCTH.2014.00040","article-title":"An update to hepatobiliary stents","volume":"3","author":"Moy","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"2025112102451055000_73.1.16.115","doi-asserted-by":"crossref","first-page":"E281","DOI":"10.1055\/a-1067-4326","article-title":"Unilateral versus bilateral endoscopic stenting in patients with unresectable malignant hilar obstruction: a systematic review and meta-analysis","volume":"8","author":"Aghaie Meybodi","year":"2020","journal-title":"Endosc Int Open"},{"key":"2025112102451055000_73.1.16.116","doi-asserted-by":"crossref","first-page":"E203","DOI":"10.1055\/a-0990-9114","article-title":"Percutaneous transhepatic biliary drainage may be the preferred preoperative drainage method in hilar cholangiocarcinoma","volume":"8","author":"Ba","year":"2020","journal-title":"Endosc Int Open"},{"key":"2025112102451055000_73.1.16.117","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/den.13298","article-title":"Endoscopic radiofrequency biliary ablation treatment: a comprehensive review","volume":"31","author":"Larghi","year":"2019","journal-title":"Dig Endosc"},{"key":"2025112102451055000_73.1.16.118","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10050952","article-title":"Feasibility and safety of endoluminal radiofrequency ablation as a rescue treatment for bilateral metal stent obstruction due to tumor ingrowth in the hilum: a pilot study","volume":"10","author":"So","year":"2021","journal-title":"J Clin Med"},{"key":"2025112102451055000_73.1.16.119","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.12.004"},{"key":"2025112102451055000_73.1.16.120","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-021-01798-2","article-title":"Outcomes and limitations of endoscopic ultrasound-guided hepaticogastrostomy in malignant biliary obstruction","volume":"21","author":"Jagielski","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"2025112102451055000_73.1.16.121","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/jgh.15089","article-title":"Durability and outcome of endoscopic ultrasound\u2010guided hepaticoduodenostomy using a fully covered metal stent for segregated right intrahepatic duct dilatation","volume":"35","author":"Ma","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"2025112102451055000_73.1.16.122","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.hpb.2018.07.014","article-title":"A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers","volume":"21","author":"Olthof","year":"2019","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.123","unstructured":"AUGIS . AUGIS: provision of services. 2016. Available: https:\/\/www.augis.org\/wp-content\/uploads\/2016\/06\/Provision-of-Services-June-2016.pdf [Accessed 28 Dec 2022]."},{"key":"2025112102451055000_73.1.16.124","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000251366.62632.d3"},{"key":"2025112102451055000_73.1.16.125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13651820801992609","article-title":"Pathological aspects of cholangiocarcinoma","volume":"10","author":"Esposito","year":"2008","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.soc.2014.09.010","article-title":"Prognostication systems as applied to primary and metastatic hepatic malignancies","volume":"24","author":"Cho","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"2025112102451055000_73.1.16.127","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/cco.2018.07.03","article-title":"Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates","volume":"7","author":"Lee","year":"2018","journal-title":"Chin Clin Oncol"},{"key":"2025112102451055000_73.1.16.128","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12333"},{"key":"2025112102451055000_73.1.16.129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2016.05.019","article-title":"Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models","volume":"223","author":"Doussot","year":"2016","journal-title":"J Am Coll Surg"},{"key":"2025112102451055000_73.1.16.130","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s11605-014-2533-1","article-title":"Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma","volume":"18","author":"Spolverato","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"2025112102451055000_73.1.16.131","first-page":"170","article-title":"Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver","volume":"140","author":"Bismuth","year":"1975","journal-title":"Surg Gynecol Obstet"},{"key":"2025112102451055000_73.1.16.132","doi-asserted-by":"publisher","DOI":"10.1080\/13651820801992617"},{"key":"2025112102451055000_73.1.16.133","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199201000-00005"},{"key":"2025112102451055000_73.1.16.134","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1177\/000313481107701246","article-title":"Klatskin tumors and the accuracy of the Bismuth-Corlette classification","volume":"77","author":"Paul","year":"2011","journal-title":"Am Surg"},{"key":"2025112102451055000_73.1.16.135","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/657309","article-title":"Prognostic impact of preoperative imaging parameters on resectability of hilar cholangiocarcinoma","volume":"2013","author":"Ruys","year":"2013","journal-title":"HPB Surg"},{"key":"2025112102451055000_73.1.16.136","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200110000-00010"},{"key":"2025112102451055000_73.1.16.137","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jamcollsurg.2012.05.025","article-title":"The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients","volume":"215","author":"Matsuo","year":"2012","journal-title":"J Am Coll Surg"},{"key":"2025112102451055000_73.1.16.138","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-009-0205-4"},{"key":"2025112102451055000_73.1.16.139","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ags3.12181","article-title":"Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center","volume":"2","author":"Lidsky","year":"2018","journal-title":"Ann Gastroenterol Surg"},{"key":"2025112102451055000_73.1.16.140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjsurg.2012.11.020","article-title":"Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma","volume":"206","author":"Zaydfudim","year":"2013","journal-title":"Am J Surg"},{"key":"2025112102451055000_73.1.16.141","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-015-0526-5","article-title":"A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma","volume":"13","author":"Ding","year":"2015","journal-title":"World J Surg Oncol"},{"key":"2025112102451055000_73.1.16.142","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00423-018-1649-2","article-title":"Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience","volume":"403","author":"Rassam","year":"2018","journal-title":"Langenbecks Arch Surg"},{"key":"2025112102451055000_73.1.16.143","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1007\/s00464-016-4788-y","article-title":"Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"30","author":"Coelen","year":"2016","journal-title":"Surg Endosc"},{"key":"2025112102451055000_73.1.16.144","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1576-8"},{"key":"2025112102451055000_73.1.16.145","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-013-1104-3"},{"key":"2025112102451055000_73.1.16.146","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(02)00033-9"},{"key":"2025112102451055000_73.1.16.147","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2003.03.091"},{"key":"2025112102451055000_73.1.16.148","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jso.25323","article-title":"Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions","volume":"119","author":"Davidson","year":"2019","journal-title":"J Surg Oncol"},{"key":"2025112102451055000_73.1.16.149","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200203000-00011"},{"key":"2025112102451055000_73.1.16.150","first-page":"127","article-title":"Laparoscopic staging in hilar cholangiocarcinoma: is it still justified","volume":"5","author":"Rotellar","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2025112102451055000_73.1.16.151","doi-asserted-by":"publisher","DOI":"10.1016\/S1091-255X(02)00005-7"},{"key":"2025112102451055000_73.1.16.152","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12441"},{"key":"2025112102451055000_73.1.16.153","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/SLA.0000000000000213","article-title":"Measured versus estimated total liver volume to preoperatively assess the adequacy of the future liver remnant: which method should we use?","volume":"258","author":"Ribero","year":"2013","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.154","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/SLA.0b013e3181b674df","article-title":"Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry","volume":"250","author":"Kishi","year":"2009","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1477-2574.2010.00184.x","article-title":"AHPBA\/SSO\/SSAT sponsored consensus conference on multidisciplinary treatment of hepatocellular carcinoma","volume":"12","author":"Dixon","year":"2010","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.156","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7194"},{"key":"2025112102451055000_73.1.16.157","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.RVI.0000159543.28222.73","article-title":"Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care","volume":"16","author":"Madoff","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"2025112102451055000_73.1.16.158","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.surg.2014.12.009","article-title":"A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection","volume":"157","author":"Pandanaboyana","year":"2015","journal-title":"Surgery"},{"key":"2025112102451055000_73.1.16.159","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4240\/wjgs.v8.i2.124","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy: from technical evolution to oncological benefit","volume":"8","author":"Li","year":"2016","journal-title":"World J Gastrointest Surg"},{"key":"2025112102451055000_73.1.16.160","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2016.0083"},{"key":"2025112102451055000_73.1.16.161","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31824856f5"},{"key":"2025112102451055000_73.1.16.162","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003941","article-title":"An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence","volume":"95","author":"Cai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025112102451055000_73.1.16.163","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00268-017-4181-6","article-title":"Operative results and oncologic outcomes of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH) in patients with unresectable colorectal liver metastases: a systematic review and meta-analysis","volume":"42","author":"Moris","year":"2018","journal-title":"World J Surg"},{"key":"2025112102451055000_73.1.16.164","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-018-6930-7","article-title":"Totally laparoscopic ALPPS: bilobar procedure with preservation of the S3 portobiliary triad","volume":"26","author":"Ferko","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2025112102451055000_73.1.16.165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.hpb.2016.10.004","article-title":"Transition from open to laparoscopic ALPPS for patients with very small FLR: the initial experience","volume":"19","author":"Machado","year":"2017","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.166","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jviscsurg.2016.11.004","article-title":"Totally laparoscopic ALPPS for multiple and bilobar colorectal metastases (with video)","volume":"154","author":"Machado","year":"2017","journal-title":"J Visc Surg"},{"key":"2025112102451055000_73.1.16.167","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1245\/s10434-016-5620-6","article-title":"Total laparoscopic reversal ALPPS","volume":"24","author":"Machado","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2025112102451055000_73.1.16.168","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.hpb.2016.10.008","article-title":"High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the International ALPPS Registry","volume":"19","author":"Olthof","year":"2017","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.169","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/13651820801992666","article-title":"Preoperative biliary drainage before resection for cholangiocarcinoma (Pro)","volume":"10","author":"Nimura","year":"2008","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.170","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-007-0796-6"},{"key":"2025112102451055000_73.1.16.171","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2012.09.019"},{"key":"2025112102451055000_73.1.16.172","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-010-0298-1"},{"key":"2025112102451055000_73.1.16.173","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SLA.0000000000002797","article-title":"10th anniversary of ALPPS-lessons learned and quo vadis","volume":"269","author":"Lang","year":"2019","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.174","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/liv.14089","article-title":"Surgery for cholangiocarcinoma","volume":"39 Suppl 1","author":"Cillo","year":"2019","journal-title":"Liver Int"},{"key":"2025112102451055000_73.1.16.175","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6519"},{"key":"2025112102451055000_73.1.16.176","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.12.005"},{"key":"2025112102451055000_73.1.16.177","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jso.23762","article-title":"Outcomes in biliary malignancy","volume":"110","author":"Groot Koerkamp","year":"2014","journal-title":"J Surg Oncol"},{"key":"2025112102451055000_73.1.16.178","first-page":"437","article-title":"Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy","volume":"24","author":"Kuhlmann","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025112102451055000_73.1.16.179","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29824"},{"key":"2025112102451055000_73.1.16.180","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1002\/cncr.27492","article-title":"The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases","volume":"118","author":"de Jong","year":"2012","journal-title":"Cancer"},{"key":"2025112102451055000_73.1.16.181","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/SLA.0b013e3182368f85","article-title":"Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma","volume":"254","author":"Ribero","year":"2011","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.182","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20906"},{"key":"2025112102451055000_73.1.16.183","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0003-2"},{"key":"2025112102451055000_73.1.16.184","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/SLA.0000000000001944","article-title":"Residual carcinoma in situ at the ductal stump has a negative survival effect: an analysis of early-stage cholangiocarcinomas","volume":"266","author":"Tsukahara","year":"2017","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.185","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3748\/wjg.v24.i12.1332","article-title":"Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma","volume":"24","author":"Shiraki","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2025112102451055000_73.1.16.186","doi-asserted-by":"publisher","DOI":"10.1007\/BF01658686"},{"key":"2025112102451055000_73.1.16.187","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s005340050035","article-title":"Right hepatic lobectomy and subsegmental resection of the left caudate lobe for gallbladder carcinoma involving the hepatic hilus: preservation of the ventral portion of the left caudate lobe","volume":"5","author":"Yamamoto","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"2025112102451055000_73.1.16.188","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000193604.72436.63"},{"key":"2025112102451055000_73.1.16.189","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.surg.2017.10.028","article-title":"The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US extrahepatic biliary malignancy consortium","volume":"163","author":"Bhutiani","year":"2018","journal-title":"Surgery"},{"key":"2025112102451055000_73.1.16.190","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200307000-00011"},{"key":"2025112102451055000_73.1.16.191","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/hpb.12067","article-title":"Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma","volume":"16","author":"Tamoto","year":"2014","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.192","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10353-017-0507-8","article-title":"Hilar en bloc resection for hilar cholangiocarcinoma in patients with limited liver capacities-preserving parts of liver segment 4","volume":"50","author":"Jonas","year":"2018","journal-title":"Eur Surg"},{"key":"2025112102451055000_73.1.16.193","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3748\/wjg.v9.i4.706","article-title":"Right trisectionectomy for primary liver cancer","volume":"9","author":"Rui","year":"2003","journal-title":"World J Gastroenterol"},{"key":"2025112102451055000_73.1.16.194","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/SLA.0b013e3181be0085","article-title":"Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy","volume":"251","author":"Shimizu","year":"2010","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.195","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/SLA.0000000000000584","article-title":"Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy","volume":"259","author":"Hosokawa","year":"2014","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.196","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/SLA.0b013e31819a6c10","article-title":"Clinical significance of biliary vascular anatomy of the right liver for hilar cholangiocarcinoma applied to left hemihepatectomy","volume":"249","author":"Shimizu","year":"2009","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.197","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.hpb.2016.05.002","article-title":"Liver resection for perihilar cholangiocarcinoma - why left is sometimes right","volume":"18","author":"Govil","year":"2016","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.198","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.hpb.2017.10.003","article-title":"Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium","volume":"20","author":"Schimizzi","year":"2018","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.199","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1245\/s10434-016-5381-2","article-title":"Significance of vascular resection and reconstruction in surgery for hilar cholangiocarcinoma: with special reference to hepatic arterial resection and reconstruction","volume":"23","author":"Matsuyama","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2025112102451055000_73.1.16.200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.hbpd.2018.03.003","article-title":"Assessment of clinical outcomes of advanced hilar cholangiocarcinoma","volume":"17","author":"Chen","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2025112102451055000_73.1.16.201","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jamasurg.2016.1769","article-title":"Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis","volume":"151","author":"Giuliante","year":"2016","journal-title":"JAMA Surg"},{"key":"2025112102451055000_73.1.16.202","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.amjsurg.2015.05.015","article-title":"Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review","volume":"210","author":"Kambakamba","year":"2015","journal-title":"Am J Surg"},{"key":"2025112102451055000_73.1.16.203","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1245\/s10434-017-6095-9","article-title":"Identification of patients for adjuvant therapy after resection of carcinoma of the extrahepatic bile ducts: a propensity score-matched analysis","volume":"24","author":"Ecker","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2025112102451055000_73.1.16.204","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00595-016-1354-0","article-title":"Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis","volume":"47","author":"Mizuno","year":"2017","journal-title":"Surg Today"},{"key":"2025112102451055000_73.1.16.205","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30915-X"},{"key":"2025112102451055000_73.1.16.206","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejso.2010.10.011","article-title":"Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma","volume":"37","author":"Oshiro","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"2025112102451055000_73.1.16.207","first-page":"281","article-title":"Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes","volume":"2","author":"Guglielmi","year":"2013","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2025112102451055000_73.1.16.208","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw063"},{"key":"2025112102451055000_73.1.16.209","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/bjs.10921","article-title":"Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma","volume":"105","author":"Bird","year":"2018","journal-title":"Br J Surg"},{"key":"2025112102451055000_73.1.16.210","unstructured":"Malik H . Ensuring quality in centres. Cholangiocarcinoma-UK Conference 2022; 2022 Available: https:\/\/www.basl.org.uk\/index.cfm\/content\/page\/cid\/28"},{"key":"2025112102451055000_73.1.16.211","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.hpb.2018.11.013","article-title":"Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma","volume":"21","author":"Idrees","year":"2019","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.212","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s11605-022-05465-z","article-title":"Defining facility volume threshold for optimization of short- and long-term outcomes in patients undergoing resection of perihilar cholangiocarcinoma","volume":"27","author":"Elshami","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"2025112102451055000_73.1.16.213","first-page":"1","article-title":"Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation","volume":"74","author":"Stieber","year":"1989","journal-title":"Int Surg"},{"key":"2025112102451055000_73.1.16.214","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200004270-00019"},{"key":"2025112102451055000_73.1.16.215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejso.2007.10.005","article-title":"Surgery for hilar cholangiocarcinoma: the Leeds experience","volume":"34","author":"Hidalgo","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"2025112102451055000_73.1.16.216","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.20812.x"},{"key":"2025112102451055000_73.1.16.217","doi-asserted-by":"publisher","DOI":"10.1053\/lv.2000.6143"},{"key":"2025112102451055000_73.1.16.218","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.219","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","article-title":"Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary","volume":"215","author":"Rosen","year":"2012","journal-title":"J Am Coll Surg"},{"key":"2025112102451055000_73.1.16.220","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.008"},{"key":"2025112102451055000_73.1.16.221","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156127","article-title":"Strict selection alone of patients undergoing liver transplantation for hilar cholangiocarcinoma is associated with improved survival","volume":"11","author":"Mantel","year":"2016","journal-title":"PLoS One"},{"key":"2025112102451055000_73.1.16.222","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/PAS.0000000000000588","article-title":"Prognostic significance of the histologic response of perihilar cholangiocarcinoma to preoperative neoadjuvant chemoradiation in liver explants","volume":"40","author":"Lehrke","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2025112102451055000_73.1.16.223","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113157","article-title":"Selected patients with unresectable perihilar cholangiocarcinoma (pCCA) derive long-term benefit from liver transplantation","volume":"12","author":"Azad","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2025112102451055000_73.1.16.224","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1097\/SLA.0000000000005190","article-title":"Meta-analysis and meta-regression of survival after liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"274","author":"Cambridge","year":"2021","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jamcollsurg.2015.01.064","article-title":"Is liver transplantation appropriate for patients with potentially resectable de novo hilar cholangiocarcinoma?","volume":"221","author":"Croome","year":"2015","journal-title":"J Am Coll Surg"},{"key":"2025112102451055000_73.1.16.226","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"key":"2025112102451055000_73.1.16.227","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000108702.45715.81"},{"key":"2025112102451055000_73.1.16.228","doi-asserted-by":"crossref","first-page":"208","DOI":"10.12659\/AOT.895936","article-title":"Intrahepatic cholangiocarcinoma in the liver explant after liver transplantation: histological differentiation and prognosis","volume":"21","author":"Takahashi","year":"2016","journal-title":"Ann Transplant"},{"key":"2025112102451055000_73.1.16.229","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajt.12591","article-title":"\u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?","volume":"14","author":"Sapisochin","year":"2014","journal-title":"Am J Transplant"},{"key":"2025112102451055000_73.1.16.230","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \"very early\" intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"2025112102451055000_73.1.16.231","doi-asserted-by":"crossref","first-page":"42","DOI":"10.12659\/AOT.901504","article-title":"Clinicopathological features and prognosis of intrahepatic cholangiocarcinoma after liver transplantation and resection","volume":"22","author":"Jung","year":"2017","journal-title":"Ann Transplant"},{"key":"2025112102451055000_73.1.16.232","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/lt.25737","article-title":"Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular\u2010cholangiocarcinoma in the setting of cirrhosis","volume":"26","author":"De Martin","year":"2020","journal-title":"Liver Transpl"},{"key":"2025112102451055000_73.1.16.233","doi-asserted-by":"crossref","first-page":"401","DOI":"10.15403\/jgld.2014.1121.253.y90","article-title":"Multimodal therapy including yttrium-90 radioembolization as a bridging therapy to liver transplantation for a huge and locally advanced intrahepatic cholangiocarcinoma","volume":"25","author":"Rayar","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"2025112102451055000_73.1.16.234","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112102451055000_73.1.16.235","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00050"},{"key":"2025112102451055000_73.1.16.236","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10776"},{"key":"2025112102451055000_73.1.16.237","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/HEP.0000000000000046","article-title":"Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial","volume":"77","author":"Jeong","year":"2023","journal-title":"Hepatology"},{"key":"2025112102451055000_73.1.16.238","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"2025112102451055000_73.1.16.239","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a010676"},{"key":"2025112102451055000_73.1.16.240","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.3605"},{"key":"2025112102451055000_73.1.16.241","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"2025112102451055000_73.1.16.242","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605779"},{"key":"2025112102451055000_73.1.16.243","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.21.00679","article-title":"Modified FOLFIRINOX versus CISGEM chemotherapy for patients with advanced biliary tract cancer (PRODIGE 38 AMEBICA): a randomized phase II study","volume":"40","author":"Phelip","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025112102451055000_73.1.16.244","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy282","article-title":"Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA)","volume":"29","author":"Sakai","year":"2018","journal-title":"Ann Oncol"},{"key":"2025112102451055000_73.1.16.245","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and NAB-paclitaxel for the treatment of advanced biliary tract cancers","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol"},{"key":"2025112102451055000_73.1.16.246","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.4_suppl.LBA490","article-title":"SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers","volume":"41","author":"Shroff","year":"2023","journal-title":"J Clin Oncol"},{"key":"2025112102451055000_73.1.16.247","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00027-9"},{"key":"2025112102451055000_73.1.16.248","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(21)00486-1"},{"key":"2025112102451055000_73.1.16.249","doi-asserted-by":"crossref","unstructured":"Oh D-Y , Ruth He A , Qin S , et al . Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evidence 2022;1. doi:10.1056\/EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015"},{"key":"2025112102451055000_73.1.16.250","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00727-4"},{"key":"2025112102451055000_73.1.16.251","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0368"},{"key":"2025112102451055000_73.1.16.252","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1000"},{"key":"2025112102451055000_73.1.16.253","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S2468-1253(19)30189-X","article-title":"Safety and activity of Ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study","volume":"4","author":"Lowery","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112102451055000_73.1.16.254","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.annonc.2021.04.012","article-title":"Practical considerations in screening for genetic alterations in cholangiocarcinoma","volume":"32","author":"Bekaii-Saab","year":"2021","journal-title":"Ann Oncol"},{"key":"2025112102451055000_73.1.16.255","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1200\/JCO.2020.38.4_suppl.578","article-title":"Primary versus metastatic intrahepatic cholangiocarcinoma: a comparative comprehensive genomic profiling (CGP) study","volume":"38","author":"Ross","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025112102451055000_73.1.16.256","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2021-CT010","article-title":"Primary results of phase 2 FOENIX-Cca2: the irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions\/rearrangements","volume":"81","author":"Goyal","year":"2021","journal-title":"Cancer Res"},{"key":"2025112102451055000_73.1.16.257","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1200\/JCO.2021.39.3_suppl.265","article-title":"Final results from a phase II study of Infigratinib (BGJ398), an FGFR-selective tyrosine kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma harboring an FGFR2 gene fusion or rearrangement","volume":"39","author":"Javle","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025112102451055000_73.1.16.258","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41416-018-0334-0","article-title":"Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma","volume":"120","author":"Mazzaferro","year":"2019","journal-title":"Br J Cancer"},{"key":"2025112102451055000_73.1.16.259","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1200\/JCO.2021.39.3_suppl.299","article-title":"Zanidatamab (ZW25) in Her2-positive biliary tract cancers (BTCS): results from a phase I study","volume":"39","author":"Meric-Bernstam","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025112102451055000_73.1.16.260","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1669"},{"key":"2025112102451055000_73.1.16.261","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0697"},{"key":"2025112102451055000_73.1.16.262","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1200\/JCO.2021.39.3_suppl.303","article-title":"Effect of FGFR2 alterations on survival in patients receiving systemic chemotherapy for intrahepatic cholangiocarcinoma","volume":"39","author":"Abou-Alfa","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025112102451055000_73.1.16.263","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30157-1"},{"key":"2025112102451055000_73.1.16.264","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S1470-2045(23)00242-5","article-title":"Zanidatamab for Her2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2B study","volume":"24","author":"Harding","year":"2023","journal-title":"Lancet Oncol"},{"key":"2025112102451055000_73.1.16.265","doi-asserted-by":"crossref","first-page":"751","DOI":"10.21037\/jgo.2019.03.10","article-title":"Frequency and prognostic significance of Isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review","volume":"10","author":"Boscoe","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"2025112102451055000_73.1.16.266","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(20)30321-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial","volume":"21","author":"Subbiah","year":"2020","journal-title":"Lancet Oncol"},{"key":"2025112102451055000_73.1.16.267","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/hpb.12150","article-title":"Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review","volume":"16","author":"Grendar","year":"2014","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.268","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hbpd.2020.02.007","article-title":"Neoadjuvant chemoradiotherapy before resection of perihilar cholangiocarcinoma: a systematic review","volume":"19","author":"Baltatzis","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2025112102451055000_73.1.16.269","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jso.24833","article-title":"Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada","volume":"117","author":"Loveday","year":"2018","journal-title":"J Surg Oncol"},{"key":"2025112102451055000_73.1.16.270","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-1459-x","article-title":"A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"15","author":"Ren","year":"2020","journal-title":"Radiat Oncol"},{"key":"2025112102451055000_73.1.16.271","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229292","article-title":"The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: a systematic review and meta-analysis","volume":"15","author":"Ke","year":"2020","journal-title":"PLoS ONE"},{"key":"2025112102451055000_73.1.16.272","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/hpb.12413","article-title":"A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma","volume":"17","author":"Cho","year":"2015","journal-title":"HPB (Oxford)"},{"key":"2025112102451055000_73.1.16.273","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.2219"},{"key":"2025112102451055000_73.1.16.274","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00066-018-1367-2","article-title":"Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review","volume":"195","author":"Lee","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"2025112102451055000_73.1.16.275","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180688","article-title":"Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review","volume":"92","author":"Frakulli","year":"2019","journal-title":"Br J Radiol"},{"key":"2025112102451055000_73.1.16.276","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.08.013"},{"key":"2025112102451055000_73.1.16.277","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2710"},{"key":"2025112102451055000_73.1.16.278","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.3778"},{"key":"2025112102451055000_73.1.16.279","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2018.11.015","article-title":"Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced Intrahepatic and extrahepatic cholangiocarcinoma","volume":"132","author":"Brunner","year":"2019","journal-title":"Radiother Oncol"},{"key":"2025112102451055000_73.1.16.280","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13014-017-0818-8","article-title":"Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer","volume":"12","author":"Mutsaers","year":"2017","journal-title":"Radiat Oncol"},{"key":"2025112102451055000_73.1.16.281","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.11.026"},{"key":"2025112102451055000_73.1.16.282","first-page":"40","article-title":"Short-course palliative radiation therapy leads to excellent bleeding control: a single centre retrospective study","volume":"14","author":"Sapienza","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"2025112102451055000_73.1.16.283","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00270-017-1827-6","article-title":"A systematic review and meta-analysis of intraluminal brachytherapy versus stent alone in the treatment of malignant obstructive jaundice","volume":"41","author":"Xu","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2025112102451055000_73.1.16.284","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32487-5"},{"key":"2025112102451055000_73.1.16.285","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00818"},{"key":"2025112102451055000_73.1.16.286","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2019.08.041","article-title":"Quality of life outcomes after stereotactic ablative radiation therapy (SABR) versus standard of care treatments in the oligometastatic setting: a secondary analysis of the SABR-COMET randomized trial","volume":"105","author":"Olson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025112102451055000_73.1.16.287","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30537-4"},{"key":"2025112102451055000_73.1.16.288","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/SPC.0b013e32835f1e2f","article-title":"The palliation of cholangiocarcinoma","volume":"7","author":"Shariff","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"2025112102451055000_73.1.16.289","article-title":"Early palliative care for adults with advanced cancer","volume":"6","author":"Haun","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025112102451055000_73.1.16.290","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.3390\/cancers13205074","article-title":"Quality of life and symptom management in advanced biliary tract cancers","volume":"13","author":"Hunter","year":"2021","journal-title":"Cancers"},{"key":"2025112102451055000_73.1.16.291","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2020-002801"},{"key":"2025112102451055000_73.1.16.292","article-title":"Pharmacological interventions for pruritus in adult palliative care patients","volume":"11","author":"Siemens","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025112102451055000_73.1.16.293","doi-asserted-by":"crossref","unstructured":"Alessy SA , Davies E , Rawlinson J , et al . Clinical nurse specialists and survival in patients with cancer: the UK National cancer experience survey. BMJ Support Palliat Care 2022. doi:10.1136\/bmjspcare-2021-003445 [Epub ahead of print 21 Apr 2022].","DOI":"10.1136\/bmjspcare-2021-003445"},{"key":"2025112102451055000_73.1.16.294","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw324"},{"key":"2025112102451055000_73.1.16.295","doi-asserted-by":"crossref","unstructured":"Graf J , Stengel A . Psychological burden and psycho-oncological interventions for patients with hepatobiliary cancers\u2013a systematic review. Front Psychol 2021;12. doi:10.3389\/fpsyg.2021.662777","DOI":"10.3389\/fpsyg.2021.662777"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-330029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T10:47:02Z","timestamp":1763722022000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-330029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":295,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,7]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/gutjnl-2023-330029"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-330029","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}